A beta-blocker, propranolol, decreases the efficacy from enzyme replacement therapy in Pompe disease.
about
A beta-blocker, propranolol, decreases the efficacy from enzyme replacement therapy in Pompe disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A beta-blocker, propranolol, d ...... ment therapy in Pompe disease.
@ast
A beta-blocker, propranolol, d ...... ment therapy in Pompe disease.
@en
type
label
A beta-blocker, propranolol, d ...... ment therapy in Pompe disease.
@ast
A beta-blocker, propranolol, d ...... ment therapy in Pompe disease.
@en
prefLabel
A beta-blocker, propranolol, d ...... ment therapy in Pompe disease.
@ast
A beta-blocker, propranolol, d ...... ment therapy in Pompe disease.
@en
P2093
P2860
P1476
A beta-blocker, propranolol, d ...... ement therapy in Pompe disease
@en
P2093
Dwight D Koeberl
Priya S Kishnani
Richard Steet
Songtao Li
P2860
P304
P356
10.1016/J.YMGME.2015.09.012
P50
P577
2015-10-03T00:00:00Z